The Pharma industry is up 2.6% in the last week, with Eli Lilly up 2.5%. In the same time, Arvinas was down 18%. This takes the industry's 12 month performance to a gain of 18%. Looking forward, earnings are forecast to grow by 24% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 06 Jun 2024 | US$1.9t | US$358.3b | US$14.1b | 15.6x | 135.7x | 5.3x |
Sat, 04 May 2024 | US$1.8t | US$358.0b | US$13.8b | 21.4x | 131x | 5.1x |
Mon, 01 Apr 2024 | US$1.9t | US$355.2b | US$22.7b | 22.7x | 84.2x | 5.4x |
Wed, 28 Feb 2024 | US$1.9t | US$355.2b | US$23.8b | 24.4x | 80.1x | 5.4x |
Fri, 26 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 26x | 51.8x | 4.7x |
Sun, 24 Dec 2023 | US$1.7t | US$375.2b | US$33.9b | 26.7x | 49.3x | 4.4x |
Tue, 21 Nov 2023 | US$1.6t | US$375.1b | US$33.9b | 25.8x | 48.1x | 4.4x |
Thu, 19 Oct 2023 | US$1.7t | US$382.7b | US$44.7b | 17.6x | 37.5x | 4.4x |
Sat, 16 Sep 2023 | US$1.8t | US$381.8b | US$43.9b | 18x | 39.9x | 4.6x |
Mon, 14 Aug 2023 | US$1.8t | US$381.5b | US$43.9b | 18.7x | 40.2x | 4.6x |
Wed, 12 Jul 2023 | US$1.7t | US$392.8b | US$60.2b | 18.4x | 27.5x | 4.2x |
Fri, 09 Jun 2023 | US$1.7t | US$393.0b | US$60.5b | 18.8x | 28.5x | 4.4x |
Sun, 07 May 2023 | US$1.7t | US$393.0b | US$59.5b | 19.4x | 28.9x | 4.4x |
Tue, 04 Apr 2023 | US$1.6t | US$401.2b | US$69.4b | 15.9x | 23.1x | 4x |
Thu, 02 Mar 2023 | US$1.5t | US$401.2b | US$69.8b | 18.2x | 22.2x | 3.9x |
Sat, 28 Jan 2023 | US$1.7t | US$402.6b | US$69.4b | 17.7x | 24x | 4.1x |
Mon, 26 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.8x | 24.8x | 4.4x |
Wed, 23 Nov 2022 | US$1.7t | US$403.7b | US$70.7b | 15.6x | 24.6x | 4.3x |
Fri, 21 Oct 2022 | US$1.6t | US$403.4b | US$72.1b | 13.1x | 21.9x | 3.9x |
Sun, 18 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 13.8x | 22.3x | 3.9x |
Tue, 16 Aug 2022 | US$1.7t | US$403.0b | US$70.3b | 15.3x | 23.5x | 4.1x |
Thu, 14 Jul 2022 | US$1.7t | US$392.4b | US$65.1b | 21.5x | 25.7x | 4.3x |
Sat, 11 Jun 2022 | US$1.6t | US$392.5b | US$64.8b | 20.7x | 24.9x | 4.1x |
Mon, 09 May 2022 | US$1.6t | US$392.7b | US$62.9b | 20.5x | 25.9x | 4.1x |
Wed, 06 Apr 2022 | US$1.7t | US$373.8b | US$60.3b | 21.2x | 27.4x | 4.4x |
Fri, 04 Mar 2022 | US$1.6t | US$373.5b | US$60.3b | 20.6x | 25.7x | 4.2x |
Sun, 30 Jan 2022 | US$1.6t | US$363.7b | US$40.7b | 21.9x | 39.1x | 4.4x |
Tue, 28 Dec 2021 | US$1.7t | US$361.1b | US$37.9b | 22.9x | 44.1x | 4.6x |
Thu, 25 Nov 2021 | US$1.6t | US$360.7b | US$38.2b | 24x | 41.3x | 4.4x |
Sat, 23 Oct 2021 | US$1.5t | US$340.0b | US$24.9b | 20.9x | 61.2x | 4.5x |
Mon, 20 Sep 2021 | US$1.5t | US$337.6b | US$25.9b | 22.9x | 57.7x | 4.4x |
Wed, 18 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 19.3x | 62.5x | 4.8x |
73.2x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 1.36% | |
Healthcare | 3.00% | |
Pharma | 2.59% | |
Pharma | 2.59% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$831.76 | 2.5% +US$18.2b | 90.6% | PE122x | |
PFE Pfizer | US$29.55 | 6.2% +US$9.8b | -24.0% | PS3.1x | |
MRK Merck | US$129.45 | 2.8% +US$9.0b | 19.2% | PE142.2x | |
JNJ Johnson & Johnson | US$145.97 | 1.1% +US$3.7b | -7.9% | PE20.6x | |
ZTS Zoetis | US$175.82 | 2.9% +US$2.3b | 7.5% | PE33.6x |